| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc. | Chief Regulatory Officer | Common Stock | 0 | $0 | $2.94 | 22 Mar 2024 | Direct |
| CymaBay Therapeutics, Inc. | Chief Regulatory Officer | Employee Stock Option (right to buy) | 0 | 22 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024035458-dickinson-klara-2024-03-22 | CymaBay Therapeutics, Inc. | 22 Mar 2024 | 9 | $0 | 4 | Chief Regulatory Officer | 22 Mar 2024, 17:02 |
| /report/000106299324001433-dickinson-klara-2024-01-24 | CymaBay Therapeutics, Inc. | 24 Jan 2024 | 2 | $0 | 4 | Chief Regulatory Officer | 26 Jan 2024, 18:30 |
| /report/000106299323001491-dickinson-klara-2023-01-25 | CymaBay Therapeutics, Inc. | 25 Jan 2023 | 1 | $0 | 4 | Chief Regulatory Officer | 27 Jan 2023, 15:27 |
| /report/000106299322001701-dickinson-klara-2022-01-25 | CymaBay Therapeutics, Inc. | 25 Jan 2022 | 1 | $0 | 4 | Chief Regulatory Officer | 27 Jan 2022, 15:56 |